List of Contents

Single-Photon Emission Computed Tomography (SPECT) Market Size, Share, and Trends 2024 to 2034

The global single-photon emission computed tomography (SPECT) market size accounted for USD 3.17 billion in 2024, grew to USD 3.38 billion in 2025 and is predicted to surpass around USD 6.06 billion by 2034, representing a healthy CAGR of 6.69% between 2024 and 2034. The North America single-photon emission computed tomography (SPECT) market size is calculated at USD 1.39 billion in 2024 and is expected to grow at a fastest CAGR of 6.79% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 2591
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Single-Photon Emission Computed Tomography (SPECT) Market 

5.1. COVID-19 Landscape: Single-Photon Emission Computed Tomography (SPECT) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Single-Photon Emission Computed Tomography (SPECT) Market, By Type

8.1. Single-Photon Emission Computed Tomography (SPECT) Market, by Type, 2024-2034

8.1.1. Standalone SPECT Systems

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Hybrid SPECT Systems

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Single-Photon Emission Computed Tomography (SPECT) Market, By Product

9.1. Single-Photon Emission Computed Tomography (SPECT) Market, by Product, 2024-2034

9.1.1. Single Imaging Gamma Cameras

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. SPECT/CT

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Single-Photon Emission Computed Tomography (SPECT) Market, By Application 

10.1. Single-Photon Emission Computed Tomography (SPECT) Market, by Application, 2024-2034

10.1.1. Cariology

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Oncology

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Neurology

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Single-Photon Emission Computed Tomography (SPECT) Market, By End-User 

11.1. Single-Photon Emission Computed Tomography (SPECT) Market, by End-User, 2024-2034

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Diagnostic Centeres

11.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Single-Photon Emission Computed Tomography (SPECT) Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.2. Market Revenue and Forecast, by Product (2021-2034)

12.1.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.4. Market Revenue and Forecast, by End-User (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Product (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End-User (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.2. Market Revenue and Forecast, by Product (2021-2034)

12.2.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.4. Market Revenue and Forecast, by End-User (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Product (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End-User (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Product (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End-User (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Product (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End-User (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.2. Market Revenue and Forecast, by Product (2021-2034)

12.3.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.4. Market Revenue and Forecast, by End-User (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Product (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End-User (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Product (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End-User (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Product (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End-User (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.2. Market Revenue and Forecast, by Product (2021-2034)

12.4.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.4. Market Revenue and Forecast, by End-User (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Product (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End-User (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Product (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End-User (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Product (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End-User (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Product (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End-User (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Product (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End-User (2021-2034)

Chapter 13. Company Profiles

13.1. Mediso Ltd

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Siemens Healthcare AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. General Electric Co.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Bruker Co.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. MiE GmbH

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Digirad Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Spectrum Dynamics Medical Inc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client